Native Advertising Part 3: Life Science Q&A With GEN’s Bill Levine
A number of mainstream media outlets — including the New York Times and Fortune — have been early adopters of native advertising. But what about trade publications? And more sp
Native Advertising Part 2: Both Sides of the Debate
Love it or loathe it, the world of media and advertising has changed. With budget-crunched newsrooms cutting their staff to the bone, publications are exploring new advertising mod
Native Advertising Part 1: What Is It and Why Should I Care?
There’s a lot of buzz about native advertising in the marketing and media universe. But for all of the talk, it seems few people really know what native advertising is. Results f
2014 Snapshot: How the Golden State Fared in Biotech
California is known as an innovator in the national and global life sciences community, garnering more federal biomedical research dollars than any other state in the country. As a
How to Make Twitter Not Fun
Make no mistake. Twitter can be a fun and effective vehicle for engaging with the people who influence your company’s success. But for those in highly regulated industries such a
It’s Time to Debunk Lung Cancer Myths
November is Lung Cancer Awareness month. But what does awareness really mean? The truth is, it depends on the disease. For many types of cancer, awareness efforts center on prevent
Usability: Making Better Websites with Dead Simple User Experience
Let’s get something straight: We’re all marketing to humans. Yes, customers’ perspectives, experiences and industries may differ — even within the life sciences industry. B
Top 10 Biotech IPOs of 2014: West Coast Dominates
What was the most successful biotech IPO of 2014? Look no further than Ultragenyx. A special report by Fierce Biotech says that the Novato, Calif., maker of treatments for rare and
How Life Science PR Pros Can Make Reporters’ Job Easier
In the journalism world, there has always been a stigma associated with public relations. Journalists are seen as the ones who write fair and unbiased stories, while PR practitione
Replacing Adderall: Medicines to Change the World (Part I)
It’s a sad beginning to my series on medications set to change society and the way we live our lives. Shares in the promising biotech Alcobra Pharma plummeted 50 percent this wee